Friday, 27 March 2020

BioLargo Spotlight: A Look at Another Odor-No-More Odor and VOC Control System for a Cannabis Greenhouse

Indoor cannabis grow vent-mounted air quality control

BioLargo’s air quality control products division Odor-No-More, Inc. is known for delivering the best odor and VOC control product science has to offer – CupriDyne® Clean – to industries like waste handling, wastewater treatment, and most recently to the cannabis and hemp industry. Our products are adored by operators because of their ability to eliminate odor-causing compounds instantly upon contact, without requiring fragrances, all while being eco-friendly and safe to use.

Last year Odor-No-More signed a 5-year white-label distribution agreement with Cannabusters, Inc. to service the cannabis and hemp industry with our patented odor and VOC control products. Cannabusters is working diligently to expand sales of the products in 2020.

ONM odor and VOC control ring nozzles
A great example of the Cannabusters and Odor-No-More collaboration can be   seen in their latest project where they teamed up to solve a cannabis growing facility’s air quality control challenges. Odor-No-More air quality systems experts designed, built, and helped the facility owners install odor and VOC control systems at a cannabis greenhouse grow facility in Colorado, and Cannabusters will deliver odor and VOC control products to address the customer’s air quality into the future. The system designed by Odor-No-More, uses “ring-mounted nozzles” on the exhaust vents of the facility in order to ensure the air leaving the facility meets local and state regulations on odor emissions, and ensures the facility’s neighbors stay happy.

As per the white label distribution agreement, Cannabusters uses Odor-No-More experts to design, build, and install each and every odor and VOC control system their customers need. This install marks another air quality control system designed, built, and delivered by Odor-No-More to a cannabis industry customer. Each install not only results in direct revenues from the equipment designed and delivered by Odor-No-More, but also results in ongoing revenues from Cannabusters sales. This particular cannabis facility consumes an estimated 10-20 gallons of CupriDyne Clean each our to efficiently and cost-effectively eliminate its odor and VOC emissions.

In the midst of the COVID-19 crisis that is affecting people and business around the globe, our business expansion efforts continue at BioLargo, and we are pushing to make 2020 a great year all the same.

Pumps and motors spec’ed and delivered by Odor-No-More

Friday, 20 March 2020

BioLargo Continuing Operations Through the COVID-19 Crisis- Answering the call for hand sanitizer production



Today (March 20) we filed a Form 8-k about BioLargo's response to the COVID-19 crisis. This press release will be distributed on Monday, March 23.

Answering the call for hand sanitizer production

Westminster, CA – March 23, 2020 – BioLargo, Inc. (OTCQB:BLGO), developer of sustainable technologies and a full-service environmental engineering company, today released a statement from its President & CEO, Dennis P. Calvert about how it and its subsidiaries are handling the ongoing COVID-19 pandemic crisis.

Dear Stockholder,

We believe that BioLargo is uniquely positioned to weather the storm of the COVID-19 crisis. Many of our major clients constitute “essential services” – such as municipalities, landfills, air force bases, and so forth. As we are supporting these essential services, our commercial units are continuing to operate and are still solving clients’ challenges every day. 

Part 1 – How the crisis is affecting our operations

Our Odor No More air quality control division provides an essential service to the waste handling industry, and will continue to do so every day. It continues installations of misting systems at waste facilities, continues to make sales calls, and continues to manufacture, sell and ship product to its customers. Odor-No-More’s joint venture in South Korea is proceeding as planned and expects to begin operations in the next 30 days. (Details Here)

Our environmental engineering division in Tennessee has a backlog of commercial opportunities. Its engineers are working every day – at home where possible, in an effort to promote social distancing. Existing clients include the seven United States Air Force (USAF) bases, its waste to energy conversion plant project on the East coast, and its magnesium extraction project in Northern California. New business opportunities continue to present themselves and they are busy making proposals and bids that are moving forward. We also have multiple bids out to serve additional U.S. Air Force bases as part of an expanded effort to serve this key client.

Although COVID-19 dominates the news, PFAS water contamination is still a priority concern for municipalities all over the country. We are cautiously optimistic about our EPA Phase II grant application to accelerate the PFAS development work to go commercial and expect to hear from the EPA soon.

Part 2 – Answering the call for a hand sanitizer

Our Canadian team at BioLargo Water has a number of assets at its disposal to answer the call to produce needed hand sanitizers in this emergency situation.  Our team is formulating a proprietary product using our core technology, in response to a Canadian government request for these high-demand products. Relaxed interim regulations from Health Canada designed to expedite product review and approval encourage company management to believe there is strong potential for rapid production and sales. Our team is uniquely qualified to serve this need with offices located at a government facility (the University of Alberta) that has a fully equipped, qualified and licensed manufacturing facility. With a team of science professionals that have already received over 70 research grants, their technical skills are well known in government circles. They have access to the chemical ingredients and formulations necessary to produce the product. Finally, BioLargo has entered into contract negotiations with a Canadian distributor to manage the selling process. Additional partners and assets are being evaluated to ensure the process can move swiftly.

BioLargo Water also continues to work on the commercial pilot project a Sunworks Farm, the last step before full commercialization of the AOS, as well as wrapping up its storm water demonstration pilot. The team has also expanded its grant application activity to support its growing list of opportunities for commercial pilots.

It also has a new Regulation Crowdfunding program available at www.waterworksfund.com and we encourage you to see that site for more details about BioLargo Water. We believe it will help us get the word out about our breakthrough science as well as create awareness of the investment opportunity.

Part 3 – How the crisis is affecting the company at large

As we all know, the COVID-19 crisis is creating dramatic changes around the world, in every facet of society. The overall drop of the stock market has contributed to extreme pressure on BioLargo’s stock. You know that we have successfully weathered a number of storms in the past, and with your continued support, we believe that we can weather this one too.

Despite the current market challenges presented by the COVID-19 outbreak, BioLargo continues to forge ahead. Assuming adequate financing and continued investor support to complement the company’s existing financing facility through Lincoln Park Capital, BioLargo stands poised to not only survive the crisis, but emerge strong and ready for growth as its technologies find adoption through partnerships around the world and as growth capital becomes accessible. It is more important than ever for the company’s allies to continue their support for the company. Together, we can be successful in building BioLargo into a world-class, leading innovator in cleantech products and services, as we know it is destined to be.

Finally, our hearts go out to every single person affected by the COVID-19 pandemic – those who have been personally and directly affected by the disease, those who have been financially burdened by its impacts, and those whose livelihoods are threatened by the prospect of a protracted economic downturn. It is our true hope and belief that this crisis comes to a speedy end, for everyone’s sake.

Part 4 – Our internal response and policies

We wanted to discuss how we as a company are promoting responsible organizational behavior to protect our employees, subcontractors, partners, and customers from spread of the virus:

  • We have formalized company-wide COVID-19 Employee Guides for both our US- and Canada-based business units that provide specific guidelines on hygiene, respiratory etiquette, social distancing, self-isolation, travel restrictions, and more 
  • We are requiring that any employee who develops cold- or flu-like symptoms stays at home and quarantine for the CDC-recommended period of 14 days, and managers are adopting highly flexible sick leave policies to accommodate such practices
  • Any employee able to carry out normal work functions from home is currently doing so
  • All company meetings are now virtual using online conferencing tools
  • All company travel to conferences, trade shows, and non-essential business development trips are postponed or canceled
  • Our sales and Business Development teams continue to keep an open dialogue with our clients to ensure the safety of all employees  
  • Safety equipment is checked daily to ensure all employees are amply protected as they are working 
  • Office and warehouse areas are sanitized several times daily for those who must work at a main location. 

Finally, we encourage any of our investors, followers, and supporters to reach out to us if they have any questions or comments about how BioLargo is handling the COVID-19 crisis, or to discuss the science and social aspects of this world event. You can reach BioLargo’s President & CEO Dennis P. Calvert by email at dennis.calvert@biolargo.com, and you can reach out to us on social media at:



About BioLargo, Inc.
BioLargo, Inc. is an innovator of technology-based products and environmental engineering solutions provider driven by a mission to “make life better”.  We feature unique disruptive solutions to deliver clean air, clean water and a clean, safe environment (www.biolargo.com). Our engineering division features experienced professional engineers dedicated to integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our industrial odor control division, Odor-No-More (www.odornomore.com) features CupriDyne Clean Industrial Odor Eliminator (www.cupridyne.com), which eliminates the odor-causing compounds and VOCs rather than masking them, and is now winning over leading companies in the solid waste handling and wastewater industries and other industries that contend with malodors and VOCs. Our subsidiary BioLargo Water (www.biolargowater.ca) develops the Advanced Oxidation System "AOS," a disruptive industrial water treatment technology designed to eliminate waterborne pathogens and recalcitrant contaminants with better energy-efficiency and lower operational costs than incumbent technologies. We are a minority stockholder of and licensor to our subsidiary Clyra Medical (www.clyramedical.com), which features effective and gentle solutions for chronic infected wounds to promote infection control and regenerative tissue therapy.

Contact Information
Dennis P. Calvert
President and CEO, BioLargo, Inc.
888-400-2863



Safe Harbor Act
This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.



Thursday, 19 March 2020

Full interview: BioLargo announces joint venture with BKT and Tomorrow Water has been finalized

Source: Proactive Investors



BioLargo (OTCQB: BLGO) CEO Dennis Calvert joined Steve Darling from Proactive in Vancouver to discuss the company finalizing their deal with BKT and Tomorrow Water in South Korea. 
Calvert discusses what this deal provides Bio Largo and also about the recent announcement about their Advanced Oxidation System

Wednesday, 18 March 2020

BioLargo, BKT, and Tomorrow Water Set to Launch Joint Venture to Manufacture and Distribute CupriDyne Clean -Based Products in South Korea


Operations commencing soon

Westminster, CA – March 18, 2020 – BioLargo, Inc. (OTCQB:BLGO), developer of sustainable technologies and a full-service environmental engineering company, announced today that its joint venture with BKT and Tomorrow Water has been finalized and the required investment funds have been transferred from BKT to BioLargo. The newly formed joint venture in South Korea will manufacture and support the distribution of odor and volatile organic compound (VOC) control products based on CupriDyne® Clean, the award-winning air quality control product produced by BioLargo’s subsidiary Odor-No-More, Inc., for the South Korean market.

Pursuant to the terms of the executed Joint Venture Framework Agreement, BKT has purchased $350,000 worth of BioLargo common stock. The parties are funding the joint venture with $150,000 from BKT and Tomorrow Water and $100,000 from BioLargo. Operations of the newly formed joint venture entity are expected to begin shortly. The parties have worked together for months to exchange information and product training, work with prospective customers, perform testing, clear any safety requirements required by the local authorities, set up physical headquarters in South Korea, secure supply chain relationships, and establish logistics surrounding distribution of CupriDyne Clean-based products in South Korea. These efforts have been underway for some time and will enable the joint venture to commence manufacturing forthwith as customers come on board.

BKT is a leading wastewater treatment solutions provider operating in the USA, South Korea and Vietnam with a reputation for adopting innovative, environmentally sustainable technologies and practices. Headquartered in Daejeon, South Korea, BKT has an extensive distribution network throughout Southeast Asia.

CupriDyne Clean is Odor-No-More’s patented product that controls odors and VOCs at a host of industrial sites like landfills, transfer stations and wastewater treatment operations. The company currently serves the largest waste handling companies in the United States. CupriDyne Clean is lauded for its gentle, non-toxic, eco-friendly, non-pesticide formula that works by eliminating odor-causing compounds rather than masking them. It is proven effective at eliminating air contaminants such as hydrogen sulfide (H2S), terpenes, and other VOCs.

CEO and Founder of BKT and Tomorrow Water Dong Woo Kim commented, “The CupriDyne Clean product performance is unmatched in the marketplace. Due to its geographic location and its excellent social infrastructure, Korea will become a gateway to Asian market. We are pleased to work with the team at BioLargo and look forward to a long-lasting partnership. We look forward to sharing the name of the joint venture as we officially launch the products soon.”

Odor-No-More President and VP of Operations for BioLargo, Joseph Provenzano, commented on the launch of the joint venture, “CupriDyne Clean has been a breakout hit among operators in the waste handling industry in the US, and we expect it to be well-received in South Korea. Our products performed extremely well in BKT’s testing for wastewater applications, and we anticipate the product will quickly make life easier for South Korean operators.”

President and CEO of BioLargo Dennis P. Calvert commented, “We are pleased to be working with the leadership team at BKT and Tomorrow Water. We anticipate that many more opportunities will arise to develop mutual business together, and we have begun those discussions. “

Note that this is the successful completion of the planned transaction, as the company had executed an MOU with BKT, Tomorrow Water and the City of Daegu in September of 2019- See this Link for Details 





About BioLargo, Inc.
BioLargo, Inc. is an innovator of technology-based products and environmental engineering solutions provider driven by a mission to “make life better”.  We feature unique disruptive solutions to deliver clean air, clean water and a clean, safe environment (www.biolargo.com). Our engineering division features experienced professional engineers dedicated to integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our industrial odor control division, Odor-No-More (www.odornomore.com) features CupriDyne Clean Industrial Odor Eliminator (www.cupridyne.com), which eliminates the odor-causing compounds and VOCs rather than masking them, and is now winning over leading companies in the solid waste handling and wastewater industries and other industries that contend with malodors and VOCs. Our subsidiary BioLargo Water (www.biolargowater.ca) develops the Advanced Oxidation System "AOS," a disruptive industrial water treatment technology designed to eliminate waterborne pathogens and recalcitrant contaminants with better energy-efficiency and lower operational costs than incumbent technologies. We are a minority stockholder of and licensor to our subsidiary Clyra Medical (www.clyramedical.com), which features effective and gentle solutions for chronic infected wounds to promote infection control and regenerative tissue therapy.

About BKT, Tomorrow Water 
BKT is a leading environmental solutions provider, specialized in biological treatment, physical filtration and integrated process design. With over 20 years of experience, BKT is committed to solving the world’s challenges of today, while designing comprehensive solutions for the needs of tomorrow. Our Proteus BBF Biofilitration (https://www.tomorrowwater.com/technology-bbf) is a proven technology that combines physical and biological filtration for advanced primary treatment, which also can be applied to secondary and tertiary treatment process. Proteus (BBF), when applied primary treatment, shrinks existing process footprints up to 80%, while maximizing economic benefits such as carbon diversion and more energy production. Our unique 2-stage AMX™ (https://www.tomorrowwater.com/technology-amx) is the most resilient Anammox system and is pioneering new shortcuts in nitrogen removal. With our diverse portfolio of technologies and dedicated team of researchers and engineers, we strive to maximize recovering the most value from waste and wastewater, while minimizing the environmental impact of it.

Contact Information
Dennis P. Calvert
President and CEO, BioLargo, Inc.
888-400-2863

Safe Harbor Act
This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.

Tuesday, 17 March 2020

BioLargo Reveals Scaled Up Commercial Design for AOS Water Treatment Technology


Manufacturing is in process


Figure 1: 500 GPM AOS Prototype (4 cylinders)

Westminster, CA – March 17, 2020 – BioLargo, Inc. (OTCQB:BLGO), developer of sustainable technologies and a full-service environmental engineering company, announced that it has designed and is manufacturing a scaled up commercial prototype of its proprietary Advanced Oxidation System (AOS) that is capable of processing 500 gallons of water per minute (“GPM”), a volume commensurate with the flowrate requirements of many commercial applications.

The new design utilizes the Spiral AOS geometry in order to achieve greater flowrate capacity without sacrificing size, and is expected to be the most energy-efficient model of the AOS technology to-date. This new design is modular and easily scalable by increasing or decreasing the number of AOS spiral reactors (the long horizontal cylinders seen here), each of which is expected to be capable of 125 GPM.

The 500 GPM AOS unit (seen in Figure 1) is suitable for use in many commercial settings, including poultry processing and the stormwater treatment and water reuse market, where the company is currently pursuing commercial piloting opportunities, as well as secondary markets which include stormwater, food & beverage, industrial and oil & gas, agriculture, and municipal.
Dr. Richard Smith, President of Biolargo Water remarked, “BioLargo’s engineering team has made it possible to accelerate the transformation of the AOS from a small, bench-scale unit to a pilot unit, and now to a commercially viable large-scale water treatment system. We are fortunate to have access to those experienced engineers.”

BioLargo Engineering President Randall Moore, a 20+ year veteran in delivering environmental engineering services, commented, “Producing a 500 GPM AOS system is the next requisite step in the commercialization of the AOS technology. Moving to this larger scale (approximately one cubic foot per second) immediately changes the AOS from a research-focused prototype into a viable, commercial water disinfection option for multiple industries. As a modular system, much higher flow rates than 500 GPM are possible. A ten by ten array of 500 GPM AOS units could effectively disinfect 50,000 GPM, needed for large scale applications such as municipal water treatment plants. This important scale-up step brings with it a world of opportunity.”

BioLargo, Inc. President & CEO Dennis P. Calvert commented, “This a momentous day for BioLargo Water and the AOS technology as it puts behind us the question of whether we can scale the AOS technology to meet the high volume needs of the very large water treatment market. It also highlights the collaborative design and manufacturing effort between BioLargo Water and our engineering team at BLEST.”

BioLargo Water currently has a crowdfunding opportunity open on the WaterWorks Crowdfunding platform through its parent company BioLargo Water Investment Group. To learn more about this opportunity to invest in BioLargo Water, go to www.waterworksfund.com.


About BioLargo, Inc.
BioLargo, Inc. is an innovator of technology-based products and environmental engineering solutions provider driven by a mission to “make life better”.  We feature unique disruptive solutions to deliver clean air, clean water and a clean, safe environment (www.biolargo.com). Our engineering division features experienced professional engineers dedicated to integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our industrial odor control division, Odor-No-More (www.odornomore.com) features CupriDyne Clean Industrial Odor Eliminator (www.cupridyne.com), which eliminates the odor-causing compounds and VOCs rather than masking them, and is now winning over leading companies in the solid waste handling and wastewater industries and other industries that contend with malodors and VOCs. Our subsidiary BioLargo Water (www.biolargowater.ca) develops the Advanced Oxidation System "AOS," a disruptive industrial water treatment technology designed to eliminate waterborne pathogens and recalcitrant contaminants with better energy-efficiency and lower operational costs than incumbent technologies. We are a minority stockholder of and licensor to our subsidiary Clyra Medical (www.clyramedical.com), which features effective and gentle solutions for chronic infected wounds to promote infection control and regenerative tissue therapy.

About BioLargo Water
BioLargo Water, Inc. is an Alberta-based Canadian corporation headquartered at Agri-Food Discovery Place located on campus at the University of Alberta in Edmonton. BioLargo Water, Inc. developed and is commercializing the Advanced Oxidation System (AOS), a patented and proprietary technology aimed at providing cost- and energy-efficient treatment of water and wastewater to enable practical and affordable safe discharge and reuse of diverse water sources. Learn more at www.biolargowater.com. BioLargo Water, Inc. is a subsidiary of BioLargo Water Investment Group, Inc. (BWIG), which a subsidiary of BioLargo, Inc. (www.biolargo.com), an innovator of technology-based products and environmental engineering solutions provider driven by a mission to “make life better”.  BioLargo features unique disruptive solutions to deliver clean air, clean water and a clean, safe environment.

Contact Information
Dennis P. Calvert
President and CEO, BioLargo, Inc.
888-400-2863

Safe Harbor Act
This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.


Thursday, 12 March 2020

BioLargo Delivers Innovative Technology And Solutions For Environmental Problems

To read the source version of this interview, visit TechCompanyNews at the following link: https://www.techcompanynews.com/biolargo-delivers-innovative-technology-and-solutions-for-environmental-problems/


BioLargo is a cleantech company that creates innovative technology and solutions for problems such as air quality, water contamination, and tough environmental problems like PFAS contamination. Below is our recent interview with Dennis P. Calvert, President & CEO of BioLargo:


Q: Could you provide our readers with a brief introduction to BioLargo?
A: What makes BioLargo especially unique as a cleantech company is that we don’t just develop innovative, patented technologies – we are also a full-service environmental engineering company that can tackle an incredibly vast range of engineering challenges thanks to our services team that averages 20+ years experience in the field (including high-profile work like dioxin remediation, anthrax remediation for the US Government, post-Katrina clean up in New Orleans, rebuilding water and wastewater systems in Haiti after its hurricane disasters and a long list of work for the Department of Defense). Individually, these components of our business are important, but together they create an environment where we are capable of solving a wide array of tough environmental challenges. This, in the end, is our mission – to solve tough environmental challenges and make the world a better, healthier place.

















Q: Could you tell us something more about the technologies you’re commercializing?
A: BioLargo holds over 20 issued patents for innovative cleantech technologies and processes and we are still innovating. So far, our top innovations include: 1) our AEC treatment technology for per- and poly-fluoroalkyl substances (PFAS), a water contaminant that is creating a widespread regulatory crisis to remove these ‘forever chemicals’ with municipalities and industry scrambling to find good, affordable solutions. 2) CupriDyne Clean odor and VOC control, a patented air quality control product that eliminates odor-causing compounds in the air rather than masking them now being adopted by the solid waste handling industry and with new distribution shaping up for the wastewater treatment industry. It’s an amazing product because not only is it extremely effective, its eco-friendly, non-toxic, and more affordable that other products and then 3) Our Advanced Oxidation System (AOS) a low-energy, low-cost water treatment technology that utilizes a specialized iodine electrochemical oxidative process to eliminate hard-to-remove water contaminants, while consuming record-low electrical power.

Each of these technologies are designed to be a best-in-class contender for solving a tough environmental challenge, and each is designed to be deployed into the market to validate their value proposition as we expand market share through partners around the world.
Q: You’ve recently announced crowdfunding offering of water subsidiary opportunity to invest in water treatment technology; could you tell us something more?
A: The best place to learn about BioLargo Water’s crowdfunding effort is right on their Crowdfunding Offering page, which you can find at www.waterworksfund.com.

The folks at WaterWorks had a vision to do two things: the first was to identify innovative solutions for solving modern water treatment challenges, and the second was to help accelerate the development and commercialization of technologies like these by allowing everyday people to invest in the opportunities. They recognized us as a significant water treatment innovator in line with their mission and that really meshed with their culture of pursuing innovation and opportunity.
Q: Why is now the time for a technology solution provider like BioLargo?
A: When I get this question, I often think of the famous Wayne Gretsky quote, “Skate to where the puck is going, not where it has been.”. That’s the way BioLargo works – we target the problems of tomorrow, not the problems of yesterday, and we address them with technology solutions that feature high innovation and high value so that they offer the best chance possible to disrupt their targeted markets.

A good example of this is our PFAS treatment solution, the AEC. We recognized early on that PFAS contamination was becoming an extremely hot topic and widespread problem, and we moved to start developing a treatment solution for it, receiving grant funding from the EPA to do it. We’re now positioned to be a cutting-edge PFAS treatment solution provider.

Examples of technological advancement, like our PFAS technology, were a direct result of our company culture of innovation, where we aim to empower our engineers, scientists, and business leaders to push the envelope and take risks to test new ideas. We are designed to be nimble, and more readily anticipate where the “puck” is going so that we can solve the problem of tomorrow. Our continued success has been and will continue to be ‘by-design’, recruiting the right talent and creating an environment where preparation meets opportunity.

Commercially, we continue to expand sales with national accounts and build new partner relationships like our recent manufacturing partnership with South Korea’s leading wastewater treatment company BKT and Tomorrow Water.



Q: What are some of the main objectives for BioLargo in 2020 and how do you plan to achieve them?
A: Our current, overarching goal is to continue our current transformation from a tech development company to a commercial solutions provider, meaning growing our revenues from product sales and services and exploiting the well-defined innovations and opportunities we have found.

Specifically, we intend to pursue partnership opportunities with industry leaders. Our goals include pursuing a 2-3X top-line monthly revenue growth, continued sales and marketing investment in the waste handling industry for our air quality control products and services, secure new channel partners for new markets, such as wastewater, and drive profitability. We also intend to launch our first commercial trial for our AOS clean water technology in the near future, commercialize our PFAS treatment technology, the AEC, and continue to drive commercial sales across all our product lines. We intend to invest to grow, and continue improving our balance sheet.

Monday, 9 March 2020

BioLargo, Inc. Updates The Stock Day Podcast On Commercialization of PFAS Solution



Phoenix, Arizona--(Newsfile Corp. - March 9, 2020) - The Stock Day Podcast welcomed BioLargo, Inc. (OTCQB: BLGO) ("the Company"), developer of sustainable products and a full-service environmental engineering company focused on products for air quality control, water treatment, and more. BioLargo President & CEO Dennis P. Calvert joined Stock Day Podcast host Everett Jolly for an interview about BioLargo's recent company milestones.

Jolly began the interview by asking Calvert for an update on the PFAS crisis and BioLargo's solution for this issue. "This is [being referred to as] the contaminant of the decade," said Calvert. "Some people estimate that it now touches about 98% of the world's population. [In high concentration] it has been linked to adverse health effects now and there are proposals before Congress to [designate] the contaminated sites super-fund sites which would qualify them for federal funding," Calvert explained.

Calvert then expanded on the high costs associated with the treatment of PFAS-contaminated wells, noting that well decontamination across the United States would represent a multi-billion dollar project given the current solutions available on the market. However, BioLargo has developed a scalable and cost-effective solution for this crisis. "We received an EPA grant about nine months ago and we're in application for Phase II," said Calvert. "We're advancing the work," he added, noting that this includes scaling the technology as they prepare for commercial trials.

Jolly asked about the potential of BioLargo's other innovations. Calvert commented, "Now at every level in the company, we're in discussions with industry leaders about partnering and licensing." Calvert noted that the PFAS solution represents the Company's fastest growing innovation, but expressed his confidence in the value of their additional technologies.

Jolly asked about BioLargo's financial goals. "On the financing side, the key for us is to really stay away from debt," said Calvert, noting that the Company has almost finished paying off its convertible debt. "Now we're at the point where we need to put capital to work and then push that top-line revenue dramatically forward, and also be alert for licensing," said Calvert. "It's all getting better. This painful era is behind us and we're intact and the business has never been better."

To hear Dennis Calvert's entire interview, follow the link to the podcast here: https://audioboom.com/posts/7525619-biolargo-inc-updates-the-stock-day-podcast-on-commercialization-of-pfas-solution

Investors Hangout is a proud sponsor of "Stock Day," and Stock Day Media encourages listeners to visit the company's message board at https://investorshangout.com/


About BioLargo, Inc.
BioLargo, Inc. is an innovative technology developer and environmental engineering company driven by a mission to "make life better" by delivering robust, sustainable solutions for a broad range of industries and applications, with a focus on clean water, clean air, and advanced wound care. We develop and commercialize disruptive technologies by providing the capital, support, and expertise to expedite them from "cradle" to "maturity" (www.biolargo.com). Our engineering division features experienced professional engineers dedicated to integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our industrial odor control division, Odor-No-More (www.odornomore.com) features CupriDyne Clean Industrial Odor Eliminator (www.cupridyne.com), which eliminates the odor-causing compounds and VOCs rather than masking them, and is now winning over leading companies in the solid waste handling and wastewater industries and other industries that contend with malodors and VOCs. Our subsidiary BioLargo Water (www.biolargowater.ca) develops the Advanced Oxidation System "AOS," a disruptive industrial water treatment technology designed to eliminate waterborne pathogens and recalcitrant contaminants with better energy-efficiency and lower operational costs than incumbent technologies. Our subsidiary Clyra Medical (www.clyramedical.com) features effective and gentle solutions for chronic infected wounds to promote infection control and regenerative tissue therapy.

Contact:
Name: Dennis P. Calvert
Phone: (888)-400-2863
Address: 14921 Chestnut St, Westminster CA, 92683
Email: dennis.calvert@biolargo.com

Safe Harbor Act
This press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.

About The "Stock Day" Podcast
Founded in 2013, Stock Day is the fastest growing media outlet for Nano-Cap and Micro-Cap companies. It educates investors while simultaneously working with penny stock and OTC companies, providing transparency and clarification of under-valued, under-sold Micro-Cap stocks of the market. Stock Day provides companies with customized solutions to their news distribution in both national and international media outlets. The Stock Day Podcast is the number one radio show of its kind in America. Stock Day recently launched its Video Interview Studio located in Phoenix, Arizona.

SOURCE:
Stock Day Media
602-441-3474

Monday, 2 March 2020

BioLargo, Inc. to Present March 3rd at the 2020 LD Micro Virtual Conference

LOS ANGELES, CA / ACCESSWIRE / March 2, 2020 / LD Micro, an independent resource for microcap company news, announced that BioLargo, Inc. (OTCQB:BLGO), developer of sustainable products and a full-service environmental engineering company, will be presenting at the third annual LD Micro Virtual Conference on Tuesday, March 3 at 10:40 AM PST / 1:40 PM EST. BioLargo President & CEO Dennis P. Calvert will be giving the presentation and answering questions from investors.

You can access the Archived Copy of the presentation at the following safe link:https://www.webcaster4.com/Webcast/Page/2019/33342

BioLargo has had several recent key milestones. The company's revenues grew 37% in 2019 compared to the previous year, with significant growth in its odor and VOC control subsidiary and its engineering services business unit. Its water treatment technology subsidiary BioLargo Water was recently awarded a Frost & Sullivan Technology Leadership award for its work to commercialize its patented Advanced Oxidation System (AOS). Its subsidiary Odor-No-More recently signed a Joint Venture agreement with a leading South Korean wastewater treatment solutions provider to manufacture and distribute its disruptive CupriDyne Clean odor and VOC control products in Southeast Asia.

"We are delighted to be hosting our third virtual event in order to showcase some of the truly unique names in micro-cap" stated Chris Lahiji, President of LD Micro. "There are a many people and companies who are unable to attend our live events, due to any number of reasons, so we are happy to offer an additional way for companies to present to investors without taking a lot of time out of their day-to-day operations. While virtual events will never replace the experience of sitting in the same room as other humans, it is a great format for updating the investor community and getting increased exposure."

The conference will be held via webcast and will feature over 40 companies in the small / micro-cap space and is expected to draw up to 2,000 viewers online.

View BioLargo's profile here: http://www.ldmicro.com/profile/BLGO

Profiles powered by LD Micro - News Compliments of Accesswire

About BioLargo, Inc.

BioLargo, Inc. is an innovative technology developer and environmental engineering company driven by a mission to "make life better" by delivering robust, sustainable solutions for a broad range of industries and applications, with a focus on clean water, clean air, and advanced wound care. We develop and commercialize disruptive technologies by providing the capital, support, and expertise to expedite them from "cradle" to "maturity" (www.biolargo.com). Our engineering division features experienced professional engineers dedicated to integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our industrial odor control division, Odor-No-More (www.odornomore.com) features CupriDyne Clean Industrial Odor Eliminator (www.cupridyne.com), which eliminates the odor-causing compounds and VOCs rather than masking them, and is now winning over leading companies in the solid waste handling and wastewater industries and other industries that contend with malodors and VOCs. Our subsidiary BioLargo Water (www.biolargowater.ca) develops the Advanced Oxidation System "AOS," a disruptive industrial water treatment technology designed to eliminate waterborne pathogens and recalcitrant contaminants with better energy-efficiency and lower operational costs than incumbent technologies. Our subsidiary Clyra Medical (www.clyramedical.com) features effective and gentle solutions for chronic infected wounds to promote infection control and regenerative tissue therapy.

About LD Micro

LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space. What started out as a newsletter highlighting unique companies has transformed into an event platform hosting several influential conferences annually (Invitational, Summit, and Main Event).

In 2015, LDM launched the first pure microcap index (the LDMi) to exclusively provide intraday information on the entire sector. LD will continue to provide valuable tools for the benefit of everyone in the small and microcap universe.

For those interested in attending, please contact David Scher at david@ldmicro.com or visit www.ldmicro.com for more information.

Contact:

Name: Dennis P. Calvert
Phone: (888)-400-2863
Address: 14921 Chestnut St, Westminster CA, 92683
Email: dennis.calvert@biolargo.com

SOURCE: BioLargo, Inc. via LD Micro



View source version on accesswire.com:
https://www.accesswire.com/578430/BioLargo-Inc-to-Present-March-3rd-at-the-2020-LD-Micro-Virtual-Conference

Friday, 21 February 2020

BioLargo Announces Crowdfunding Offering of Water Subsidiary Opportunity to Invest in Water Treatment Technology

PR Newswire

WESTMINSTER, Calif., Feb. 19, 2020 /PRNewswire/ -- BioLargo, Inc. (OTCQB:BLGO), developer of sustainable technologies and a full-service environmental engineering company, announced today that it has commenced a Regulation Crowdfunding offering (details at waterworksfund.com/biolargo) through its wholly-owned-subsidiary BioLargo Water Investment Group, Inc. ("BWIG") to support efforts to launch its patented water treatment technology into the $246 million poultry processing market.









Every year, nine billion chickens are processed in the United States, creating approximately 60 billion gallons of contaminated wastewater. The new technology, developed by BioLargo through its Alberta-based Canadian wholly-owned-subsidiary of BWIG, can efficiently treat this polluted water, enabling safe wastewater discharge and even water reuse.

BioLargo Water's treatment technology, called the Advanced Oxidation System (AOS), eliminates bacteria, viruses, and other pathogenic organisms, and can reduce pharmaceuticals and antibiotics. It is more effective in removing water contaminants than most standard systems typically used to treat industrial wastewater, and the treated water is clean enough for safe discharge to the environment or reuse in the facility. BioLargo Water's treatment technology also uses less power and is more affordable to purchase and operate than chlorination, ozonation, and UV radiation, providing additional cost savings to processors.

BioLargo Water's technology has been tested at a poultry farm in Canada, a microbrewery in Southern California, and at a stormwater site in Southern California.  After launching into the poultry processing market, BioLargo Water intends to enter the $44 billion markets of stormwater, food and beverage, municipal, industrial, oil and gas, and agriculture wastewater.

BioLargo Water has been awarded over 70 grants for development and commercialization of water treatment technology, is supported by more than 20 industry and academic collaborators from around the world, and has received financial support from innovation-centric agencies in the Canada and United States, including the Metropolitan Water District of Southern California.

To learn more, visit www.waterworksfund.com/biolargo.


About BioLargo, Inc.
BioLargo, Inc. is an innovative technology developer and environmental engineering company driven by a mission to "make life better" by delivering robust, sustainable solutions for a broad range of industries and applications, with a focus on clean water, clean air, and advanced wound care. We develop and commercialize disruptive technologies by providing the capital, support, and expertise to expedite them from "cradle" to "maturity" (www.biolargo.com). Our engineering division features experienced professional engineers dedicated to integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our industrial odor control division, Odor-No-More (www.odornomore.com) features CupriDyne Clean Industrial Odor Eliminator (www.cupridyne.com), which eliminates the odor-causing compounds and VOCs rather than masking them, and is now winning over leading companies in the solid waste handling and wastewater industries and other industries that contend with malodors and VOCs. Our subsidiary BioLargo Water (www.biolargowater.com) is preparing to commercialize its Advanced Oxidation System "AOS," a disruptive industrial water treatment technology designed to eliminate waterborne pathogens and recalcitrant contaminants with better energy-efficiency and lower operational costs than incumbent technologies. Our subsidiary Clyra Medical (www.clyramedical.com) features effective and gentle solutions for chronic infected wounds to promote infection control and regenerative tissue therapy.

About BioLargo Water Investment Group, Inc.
BioLargo Water Investment Group, Inc. is a wholly-owned-subsidiary of BioLargo, Inc., and the sole shareholder of BioLargo Water, Inc., a Canadian entity formed by BioLargo to develop water treatment technologies and products. BioLargo Water Investment Group was established to facilitate a vehicle in which investors are able to invest along-side BioLargo to advance and support the business plan of BioLargo Water through its piloting work and into commercialization. The structure is also organized to carefully preserve BioLargo Water's valuable Canadian status in order to encourage and maximize its ongoing financial support from its various federal sources of funding in Canada. Headquartered at Agri-Food Discovery Place located on campus at the University of Alberta in Edmonton, BioLargo Water, Inc. is preparing to commercialize the Advanced Oxidation System (AOS), a patented and proprietary technology aimed at providing cost- and energy-efficient treatment of water and wastewater to enable practical and affordable safe discharge and reuse of diverse water sources. Learn more at www.biolargowater.com.

About WaterWorks
"WaterWorks" refers to a group of companies that is owned by WWF Holdings, Inc., which includes WWF Platform, LLC, WWF Crowd, LLC, WWF Agency, LLC, and WWF Funding Portal, LLC. WWF Funding Portal, LLC is registered with the U.S. Securities and Exchange Commission ("SEC") as a funding portal and is a member of the Financial Industry Regulatory Authority ("FINRA"). Investing involves the risk of loss. Past performance is not a guarantee of future results. Investments in private companies are particularly risky and you should only consider investing if you can afford to lose your entire investment and are willing to live with the ups and downs with the industry in which you invest.

Contact Information
Dennis P. Calvert
President & CEO of BioLargo, Inc.
(888) 400-2863
Dennis.calvert@biolargo.com

Wednesday, 12 February 2020

BioLargo Expands Global Reach, Signs Joint Venture Agreement with BKT & Tomorrow Water featuring CupriDyne Clean Based Products


Westminster, CA – February 12, 2020 – BioLargo, Inc. (OTCQB:BLGO), developer of sustainable technologies and a full-service environmental engineering company announced that it had executed a “Joint Venture Framework Agreement” with a leading wastewater treatment solution provider based in South Korea (Bookang Tech Co. Ltd., “BKT”), to create a South Korean entity that would manufacture odor and VOC control products based on CupriDyne® Clean, the award-winning product of BioLargo’s subsidiary Odor-No-More, Inc. The parties intend to form the joint venture (JV) promptly and begin operations as soon as possible.

CupriDyne Clean is Odor-No-More’s patented product that controls odors and VOCs at landfills and transfer stations operated by the largest waste handling companies in the United States. CupriDyne Clean is lauded for its gentle, non-toxic, eco-friendly, non-pesticide formula that works by eliminating odor-causing compounds rather than masking them.

BKT is a leading wastewater treatment solutions provider operating in the USA, South Korea and Vietnam with a reputation for adopting innovative, environmentally sustainable technologies and practices. Headquartered in Daejeon, South Korea, BKT has an extensive distribution network throughout Southeast Asia serving more than 400 customers in South Korea alone, and has a presence in more than eight countries globally.

CEO and Founder of BKT and Tomorrow Water Dong Woo Kim commented on the formation of the JV with BioLargo, “Odor-No-More’s products have performed extremely well in our tests, and their team has demonstrated utmost expertise in creating innovative, eco-friendly solutions for air quality control in the wastewater treatment sector. We are looking forward to introducing these products to our customers.”

Under the terms of the agreement, BioLargo will invest $100,000 in the JV, while BKT and its U.S.-based subsidiary Tomorrow Water will invest $75,000 each, for proportionate non-dilutive interests. The JV will manufacture the CupriDyne Clean-based odor and VOC control product for distributors throughout Southeast Asia, including BKT. The JV must achieve minimum sales targets to maintain exclusive rights in the Asian markets, and an annual dividend of $2 million paid to BioLargo to secure exclusive rights in perpetuity. Finally, BKT has also agreed to invest $350,000 USD directly into BioLargo, Inc. through a stock purchase priced at market prices at closing, which is contemplated within 60 days.

BioLargo President & CEO Dennis P. Calvert said, “Not only is BKT a prominent and well-established solutions provider in the Southeast Asian wastewater industry, but they have demonstrated a commitment to innovation and research in the very DNA of their company. They are well-known for their quality service offering and integrity, and we at BioLargo are confident that together we will prosper through the formation of this joint venture.”

Joseph Provenzano, President of Odor-No-More, Inc. commented, “It’s uncommon to find an international distribution partner as qualified and capable as BKT, and for this reason we are highly encouraged about the potential for this joint venture to grow sales of CupriDyne Clean and related products significantly.”

About BKT, Tomorrow Water
BKT is a leading environmental solutions provider, specialized in biological treatment, physical filtration and integrated process design. With over 20 years of experience, BKT is committed to solving the world’s challenges of today, while designing comprehensive solutions for the needs of tomorrow. Our Proteus BBF Biofilitration (https://www.tomorrowwater.com/technology-bbf) is a proven technology that combines physical and biological filtration for advanced primary treatment, which also can be applied to secondary and tertiary treatment process. Proteus (BBF), when applied primary treatment, shrinks existing process footprints up to 80%, while maximizing economic benefits such as carbon diversion and more energy production. Our unique 2-stage AMX™ (https://www.tomorrowwater.com/technology-amx) is the most resilient Anammox system and is pioneering new shortcuts in nitrogen removal. With our diverse portfolio of technologies and dedicated team of researchers and engineers, we strive to maximize recovering the most value from waste and wastewater, while minimizing the environmental impact of it.

About BioLargo, Inc.
BioLargo, Inc. is an innovative technology developer and environmental engineering company driven by a mission to "make life better" by delivering robust, sustainable solutions for a broad range of industries and applications, with a focus on clean water, clean air, and advanced wound care. We develop and commercialize disruptive technologies by providing the capital, support, and expertise to expedite them from "cradle" to "maturity" (www.biolargo.com). Our engineering division features experienced professional engineers dedicated to integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our industrial odor control division, Odor-No-More (www.odornomore.com) features CupriDyne Clean Industrial Odor Eliminator (www.cupridyne.com), which eliminates the odor-causing compounds and VOCs rather than masking them, and is now winning over leading companies in the solid waste handling and wastewater industries and other industries that contend with malodors and VOCs. Our subsidiary BioLargo Water (www.biolargowater.ca) develops the Advanced Oxidation System "AOS," a disruptive industrial water treatment technology designed to eliminate waterborne pathogens and recalcitrant contaminants with better energy-efficiency and lower operational costs than incumbent technologies. Our subsidiary Clyra Medical (www.clyramedical.com) features effective and gentle solutions for chronic infected wounds to promote infection control and regenerative tissue therapy.

Contact Information
Dennis P. Calvert
President & CEO, BioLargo, Inc.
(888) 400-2863

Safe Harbor Act
This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.

Thursday, 6 February 2020

BioLargo engineers top-notch, low-cost answer to PFAS water contamination problem

Source: Proactive Investors







Scared about “forever chemicals” after watching ‘Dark Waters?’
The movie is based on a true story. Rob Bilott was a high-flying corporate defense attorney for eight years. Then he took on an environmental lawsuit that would upend his entire career — and expose a brazen, decades-long history of chemical pollution.
Sadly, people still drink water contaminated with man-made “forever chemicals." The chemicals, resistant to breaking down in the environment, are known as poly and perfluoroalkyl substances, or PFASs. They are typically used in fire retardants, oil and water repellents, furniture, waterproof clothes, take-out containers and non-stick cookware.
They are called “forever chemicals” because it could take thousands of years for them to naturally break down. These chemicals have been linked to cancers, liver damage, low birth weight and other health problems.
Fortunately, BioLargo Inc’s (OTCMKTS:BLGO) subsidiary BioLargo Engineering, Science & Technologies Inc (BLEST), has confirmed the potential of a new water treatment technology to solve the global drinking water contamination problem.
Proactive sat down with Randall Moore, who is president and CEO of BLEST, to find out about progress on a device called the Aqueous Electrostatic Concentrator (AEC) that is effective in eliminating PFAS from water. The new technology eliminates more than 99% of the two most predominant PFAS compounds – perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA).
What are some of the concerns about people being exposed to a toxic soup of PFAS chemicals?
There are numerous articles in the popular press about PFAS compounds being tied to myriad health problems, including various forms of cancer, liver and kidney disfunction, high cholesterol and weight gain. The hard, peer-reviewed science hasn’t caught up with the public demand for answers to the effects of long-term, low-level exposure as opposed to acute exposure. 
However, a couple of points are undeniable. Firstly, these compounds don’t occur in nature, so nature hasn’t yet produced a biological means to degrade them. Secondly, PFAS compounds bioaccumulate. That is, the human body doesn’t do a good job in clearing PFAS from the body, taking decades after exposure to get rid of the compounds in the bloodstream.
Can you talk about BioLargo Engineering’s PFAS technology project and the support it has received from the US Environmental Protection Agency (EPA)? 
BioLargo received a Phase I, EPA grant through the SBIR program. The grant supported the design, development and testing of the new bench scale PFAS treatment device, which we named the Aqueous Electrostatic Concentrator. The EPA has published a summary of the Phase 1 study on their website. 
How effective is BLEST’s Aqueous Electrostatic Concentrator (AEC) in eliminating PFAS chemicals?
The AEC performance exceeded our expectations, achieving over 99% removal of PFOA and PFOS in a single stage unit. In practice, we expect to use multiple stages, each stage optimized to target smaller and smaller concentrations of PFAS, until water is produced that has no detectable PFAS chemical present. Our original thinking was that PFAS would be treated like other water contaminants and that water below some threshold concentration would be acceptable for public use. However, recent legislation and events that have eroded the lack of public trust have pushed the acceptable threshold concentrations to the detection limit of the methods. Our Phase I work confirmed we can meet those ultra-low thresholds using the AEC.
Since BioLargo has completed Phase 1, which involved the design, build and testing of its technology to remove PFAS from water, what does the next phase involve?
Phase II work will involve confirming that the AEC is as effective on the rest of the PFAS target list compounds. Based on the principle of operation, it is logical to conclude that the AEC will be equally effective on the other polar PFAS compounds. However, it is important to make sure. And the best way to confirm the performance is to do the study. There’s also considerable support under Phase II for commercial development, market evaluation and penetration. By the end of Phase II, we expect to have commercial scale pilot systems in operation, treating contaminated plumes in real-world situations. 
Can you demystify the technology behind the AEC and why it’s so easy on the pocket?
The PFAS compounds of concern have functional groups on one end of the PFAS molecule that cause it to behave similarly to an ionized polar compound in solution. In other words, one end of the compound has a slight negative charge, while the other end does not exhibit an electrical charge in solution. Therefore, the PFAS molecule is attracted to an electrode that is positively charged. Our system puts a proprietary membrane in the migration path of PFAS compound, effectively capturing and retaining the contaminant. 
The amount of work done (energy expended) on the system can be very small, since the concentration of PFAS contamination even in highly contaminated water is very small. The Phase I tests demonstrated that the lower the PFAS concentrations, the less energy has to be expended to remove it. So, the operating costs can be very attractive compared to higher energy consuming technologies such as reverse osmosis. The AEC can be constructed from “off the shelf” components and doesn’t require exotic materials to operate effectively, which keeps the capital costs under control.   
With this proof of claim in hand, how far are we from seeing the AEC gain traction in the mainstream water treatment market?
There are two primary markets for PFAS treatment systems. The first, is the direct treatment of contaminated plumes of PFAS in ground water. The second is treatment of drinking water. The smallest system applicable for treating drinking water will be in the 10,000 gallon per minute range. Our initial target is the direct treatment of contaminated plumes, which can be addressed with smaller systems from 10 gallons per minute (GPM) to say, 500 GPM. Once a 500 GPM unit is in operation and demonstrates performance, we can move into the larger systems. Assuming we can secure private funding to match our recently secured Phase II EPA funds, we can have units to address the ground water plume treatment market within a year.
Would BioLargo license or partner the technology with a big player to secure the funds to make tens of thousands of units in the shortest time possible?
First, it is important to remember that our engineering and science teams at BioLargo have had extensive and successful careers dealing with some of the most significant remediation challenges. We've had long careers working with large customers and governments around the world. We joined the BioLargo family of companies so that we could put our skills to work to help solve some of the most difficult and pressing issues facing our planet, just like this PFAS situation.
While we have the experience of dealing with every facet of the execution of projects just like this one, including design, build and operate projects, we realize that the opportunity is global and will likely move so fast that we must explore all rational options to scale-up and deliver solutions as fast as possible. As always, we will be accessing how best to provide the greatest benefit and value to our clients. We obviously will need to build business relationships that support large-scale, national and international deployment. As we prove out our high-performance low-cost thesis, we believe business opportunities will expand around the world quickly. We are also looking into teaming with providers of other technologies to offer complete water solutions to the marketplace.  
How big is the PFAS clean-up market? 
The short answer is: Huge. The market is so large it’s hard to put a number to it. Environmental costs for the cleanup of previous contamination from PCBs, dioxin, lead, etc. were incredibly large. But the extent of contamination was contained within known geographic areas and the number of sites escalated more slowly over time. In comparison, PFAS contamination is seemingly ubiquitous and not as constrained by physical barriers, causing the contamination to spread almost unimpeded. The number of identified contaminated sites grows daily and the number will continue to escalate rapidly as water suppliers begin to look for contamination in earnest. There were 610 sites in 43 states as of May 2019. There are over 400 sites on military bases alone. I expect the final tally to exceed 2,000 identified sites in the US. Orange County California estimates the cost to treat the 90 wells already confirmed to be contaminated with PFAS at $850 million using conventional techniques. 
Based on our estimates of the cost of equipment required to address the market, we think the equipment market could be at least $200-$400 million for small units. Many municipalities are also installing “whole city” treatment systems, which could easily cost more than $40 million each. So, the total equipment supply market could easily exceed $1 billion. 
However, the larger costs will include maintenance, repair, and testing of the systems, adding another $2 billion. Additionally, the final disposal of the collected PFAS must be considered. The disposal costs could also exceed $2 billion. We would expect the total addressable market to grow to well over $10 billion before the cleanup is complete. The truth is that the world is just getting its arms around the breadth of the problem and they don’t yet know about our AEC high-performance low-cost solution that should help relieve some of the financial pain.
Contact the author Uttara Choudhury at uttara@proactiveinvestors.com
Follow her on Twitter: @UttaraProactive